Role of x-linked immunodeficiency (xid) and NK activity in rejection of human tumor xenotransplants in nude mice.
In order to elucidate the factors influencing the takes of human tumor xenografts in nude mice, we compared the transplantability of human tumors in nude mice with additional genetic defects in the immune system. The nude mice strains tested were classified as follows by expression of the beige gene and the x-linked immunodeficiency (xid) gene: 1) high NK nude (C57BL/6N, nu/nu), 2) low NK nude (C57BL/6 bg/bg nu/nu), 3) high NK nude with B-cell defect (CBA/N nu/nu), and 4) low NK nude with B-cell defect (NIH(S)III). Takes of human tumor xenografts including gastric carcinoma, T-cell lymphoma and B-cell lymphoma were better in nude mice with xid (CBA/N and NIH(S) III nude mice) than in nude mice without xid (B6 and beige nude mice). In addition, among the nude mice with xid expression, the takes were slightly better in nude mice with a CBA/N background than in those with a NIH(S) background. Moreover, the xenotransplantation rate in (CBA/N x C57BL/6N)F1 male nude mice with xid expression was higher than in (C57BL/6N x CBA/N)F1 males without xid expression, but did not react the same level as that in CBA/N nude. On the other hand, introduction of the beige gene into nude mice minimally improved the takes of human tumor xenografts under limited experimental conditions (inoculation of 100 x 10(5) T-cell lymphoma and 1 x 10(5) gastric carcinoma cells) despite the reduction of NK activity. In xenotransplantation of human tumors directly from patients, the take rates of the tumors were also better in CBA/N nude mice than in BALB/cA nude mice. The results in the present report confirmed the effect of xid and CBA/N genetic background on human tumor xenografts in nude mice, suggesting the existence of serum factors, possibly present in serum IgM, mediating rejection of the xenografts.
Maruo
K
K
Central Institute for Experimental Animals, Kanagawa, Japan.
Shimamura
K
K
Hioki
K
K
Itoh
M
M
Ueyama
Y
Y
Tamaoki
N
N
D000818:Animals; D003602:Cytotoxicity, Immunologic; D004406:Dysgammaglobulinemia / Q000235:genetics / Q000276:immunology*; D005260:Female; D008040:Genetic Linkage; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D007075:Immunoglobulin M / Q000172:deficiency* / Q000235:genetics; D007694:Killer Cells, Natural / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008819:Mice, Nude; D009368:Neoplasm Transplantation / Q000276:immunology*; D013154:Spleen / Q000276:immunology; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured; D014960:X Chromosome
D007075:Immunoglobulin M